Author

John W. Upham

Professor of Respiratory Medicine, The University of Queensland - Cited by 10,667 - severe asthma - immunology - lung disease - allergy - rhinovirus

Biography

John Upham is a clinical scientist and physician with longstanding research interests in the immunological basis of asthma and chronic lung disease, the role of dendritic cells in allergy and virus infections of the lung, and the development of novel approaches to severe asthma treatment.
Title
Cited by
Year
Defining a severe asthma super-responder: findings from a Delphi process
JW Upham, C Le Lievre, DJ Jackson, M Masoli, ME Wechsler, DB Price, ...The Journal of Allergy and Clinical Immunology: In Practice 9 (11), 3997-4004, 2021202
60
2021
Outcomes of protracted bacterial bronchitis in children: a 5‐year prospective cohort study
TJC Ruffles, JM Marchant, IB Masters, ST Yerkovich, DF Wurzel, ...Respirology 26 (3), 241-248, 2021202
30
2021
Sputum TNF markers are increased in neutrophilic and severe asthma and are reduced by azithromycin treatment
NM Niessen, PG Gibson, KJ Baines, D Barker, IA Yang, JW Upham, ...Allergy 76 (7), 2090-2101, 2021202
26
2021
Real world biologic use and switch patterns in severe asthma: data from the international severe asthma registry and the US CHRONICLE study
AN Menzies-Gow, C McBrien, B Unni, CM Porsbjerg, M Al-Ahmad, ...Journal of asthma and allergy, 63-78, 2022202
25
2022
Oral corticosteroids stewardship for asthma in adults and adolescents: a position paper from the Thoracic Society of Australia and New Zealand
J Blakey, LP Chung, VM McDonald, L Ruane, J Gornall, C Barton, ...Respirology 26 (12), 1112-1130, 2021202
23
2021
Duration of amoxicillin-clavulanate for protracted bacterial bronchitis in children (DACS): a multi-centre, double blind, randomised controlled trial
TJC Ruffles, V Goyal, JM Marchant, IB Masters, S Yerkovich, H Buntain, ...The Lancet Respiratory Medicine 9 (10), 1121-1129, 2021202
17
2021
Global variability in administrative approval prescription criteria for biologic therapy in severe asthma
CM Porsbjerg, AN Menzies-Gow, TN Tran, RB Murray, B Unni, SLA Ang, ...The Journal of Allergy and Clinical Immunology: In Practice 10 (5), 1202 …, 2022202
15
2022
Mepolizumab and oral corticosteroid stewardship: data from the Australian Mepolizumab Registry
D Thomas, ES Harvey, VM McDonald, S Stevens, JW Upham, ...The Journal of Allergy and Clinical Immunology: In Practice 9 (7), 2715-2724. e5, 2021202
14
2021
Add-on azithromycin reduces sputum cytokines in non-eosinophilic asthma: an AMAZES substudy
SD Shukla, SL Taylor, PG Gibson, D Barker, JW Upham, IA Yang, ...Thorax 76 (7), 733-736, 2021202
13
2021
Direct oral anticoagulants for cancer‐associated venous thromboembolisms: a systematic review and network meta‐analysis
CB Samaranayake, J Anderson, C McCabe, SF Zahir, J W. Upham, G KeirInternal Medicine Journal 52 (2), 272-281, 2022202
10
2022
Extended versus standard antibiotic course duration in children< 5 years of age hospitalized with community-acquired pneumonia in high-risk settings: four-week outcomes of a …
GB McCallum, SM Fong, K Grimwood, AM Nathan, CA Byrnes, MH Ooi, ...The Pediatric infectious disease journal 41 (7), 549-555, 2022202
8
2022
Severe asthma assessment, management and the organisation of care in Australia and New Zealand: expert forum roundtable meetings
S Maltby, VM McDonald, JW Upham, SD Bowler, LP Chung, EJ Denton, ...Internal medicine journal 51 (2), 169-180, 2021202
7
2021
‘Breathing fire’: impact of prolonged bushfire smoke exposure in people with severe asthma
T Beyene, ES Harvey, J Van Buskirk, VM McDonald, ME Jensen, ...International Journal of Environmental Research and Public Health 19 (12), 7419, 2022202
6
2022
Characterisation of the Australian adult population living with Asthma: severe-exacerbation frequency, long-term OCS use and adverse effects
KL Hancock, S Bosnic-Anticevich, JD Blakey, M Hew, LP Chung, ...Pragmatic and Observational Research, 3-58, 2022202
4
2022
Comparing the effect of acute moderate and vigorous exercise on inflammation in adults with asthma: A randomized controlled trial
HA Scott, LG Wood, EJ Williams, N Weaver, JW UphamAnnals of the American Thoracic Society 19 (11), 188-1855, 2022202
4
2022
Vaccine strain affects seroconversion after influenza vaccination in COPD patients and healthy older people
N Snape, GP Anderson, LB Irving, AG Jarnicki, AC Hurt, T Collins, Y Xi, ...npj Vaccines 7 (1), 8, 2022202
3
2022
The impact of meal dietary inflammatory index on exercise-induced changes in airway inflammation in adults with asthma
KP McDiarmid, LG Wood, JW Upham, LK MacDonald-Wicks, N Shivappa, ...Nutrients 14 (20), 492, 2022202
3
2022
Philip Morris International buys inhaler company Vectura to expand reach in electronic cigarettes
KV Carson‐Chahhoud, BR Thompson, JW Upham, ...Respirology 7 (5), 38-330, 0
2
2022
Surveillance for severe influenza and COVID-19 in patients admitted to sentinel Australian hospitals in 2020: the Influenza Complications Alert Network (FluCAN)
Surveillance for severe influenza and COVID-19 in patients admitted to sentinel Australian hospitals in 00: the Influenza Complications Alert Network (FluCAN)H Begum, DE Dwyer, M Holmes, L Irving, G Simpson, S Senenayake, ...Deakin University, 0
2
2022
Maternal diet modulates the infant microbiome and intestinal Flt3L necessary for dendritic cell development and immunity to respiratory infection
MAA Sikder, RB Rashid, T Ahmed, I Sebina, DR Howard, MA Ullah, ...Immunity 56 (5), 1098-1114. e10, 030
2
2023

Referred From: https://scholar.google.com/citations?user=cfqJZnsAAAAJ&hl=en

Cited by
Citations 10667
h-index 60
i10-index 156
Recommended Journals
Open Access Journals